Long‐Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52‐Week, Multicenter, Single‐Arm Trial.
Saved in:
| Title: | Long‐Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52‐Week, Multicenter, Single‐Arm Trial. |
|---|---|
| Authors: | Guo, Xiaohui1 (AUTHOR) bdyyguoxiaohui@sina.com, Wang, Kailiang2 (AUTHOR), Zhang, Tingting1 (AUTHOR), Ma, Jianhua3 (AUTHOR), Li, Yukun4 (AUTHOR), Jiang, Chengxia5 (AUTHOR), Liu, Jie6 (AUTHOR), Zhang, Yawei7 (AUTHOR), Bian, Fang8 (AUTHOR), Zhang, Fang9 (AUTHOR), Liu, Weijuan10 (AUTHOR), Wu, Xiaohong11 (AUTHOR), Tang, Xulei12 (AUTHOR), Wang, Yihua13 (AUTHOR), Ning, Tao14 (AUTHOR), Pang, Shuguang15 (AUTHOR), Li, Ya16 (AUTHOR), Wang, Lijun17 (AUTHOR), Sun, Jia18 (AUTHOR), Hu, Honglin19 (AUTHOR) |
| Source: | Journal of Diabetes Research. 3/23/2026, Vol. 2026, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
